Korean
Korean

New Drug R&D Venture
Multi-Target(MCMT)
Approach

Big Data for
Traditional Knowledge
Biomass

World Best
R&D Manpower

New Drug R&D Venture
Multi-Target(MCMT)
Approach

Big Data for
Traditional Knowledge
Biomass

World Best
R&D Manpower

  • Scientific & Technological prowess

    ·

    Experience and Expertise in deriving multi-target lead compounds

    ·

    Core Technology(1) Development of SyMthomics platform

    ·

    Core Technology(2) Establishment of advanced CMC infrastructure

    • News Room More

    [Press Release] NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01

    https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-exclusive-license-agreement-with-mthe...

    [Notice] MTHERA enters into MOU with Yuhan (April 2024)

    		2024-07-31

    [R&D] MT102: Selected for Scale-up TIPS, Korean Government R&D Funding Program

    		2024-07-31